Advertisement

Topics

Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology Demonstrating Superior Penetration and Tolerability

03:00 EST 13 Nov 2017 | Businesswire

This article has expired, however you can still download the PDF.
Preview:
Antikor Biopharma Limited (Antikor), a leader in developing and advancing Antibody Fragment-Drug Conjugates (FDCs), will be presenting new data at the 9th Protein and Antibody Engineering Summit (PEGS) Europe in Lisbon on 14th N...

Other Sources for this Article

Antikor Biopharma Limited
Dr Mahendra Deonarain
CEO
m.deonarain@antikor.co.uk

NEXT ARTICLE

More From BioPortfolio on "Antikor Advances Breakthrough Fragment Drug Conjugate (FDC) Technology Demonstrating Superior Penetration and Tolerability"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Antibodies
An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Pharmacy
Pharmacy is the science and technique of preparing as well as dispensing drugs and medicines. It is a health profession that links health sciences with chemical sciences and aims to ensure the safe and effective use of pharmaceutical drugs. The scope of...